Public, NASDAQ:NBIX
NASDAQ Global Select Market
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase For Endometriosis
Date: Wed, 18 Jun 2008 10:16:51 GMT
Tags:
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase For Endometriosis
Medical News Today (press release) - Jun 18, 2008
Medical News Today (press release) - Jun 18, 2008
Neurocrine Biosciences , Inc . ( Nasdaq : NBIX ) announced that the elagolix 0603 Phase IIb trial ( Petal Study ) has completed the 6 - month treatment phase.The last subject completed her Week ...
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
Date: Tue, 17 Jun 2008 14:12:56 GMT
Tags:
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
PR Newswire (press release) - Jun 17, 2008
PR Newswire (press release) - Jun 17, 2008
SAN DIEGO , June 17 / PRNewswire - FirstCall / - - Neurocrine Biosciences , Inc . NASDAQ : NBIX announced today that the elagolix 0603 Phase IIb trial ( Petal Study ) has completed the 6 - month ...
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Date: Sat, 24 May 2008 19:04:38 GMT
Tags:
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Stockhouse - May 24, 2008
Stockhouse - May 24, 2008
Neurocrine Biosciences , Inc . ( NASDAQ : NBIX ) announced today that Neurocrine Biosciences will present at the Citi Investment Research Global Health Care Conference at the Hilton New York.The ...
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Date: Tue, 13 May 2008 17:44:36 GMT
Tags:
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Earthtimes (press release) - May 13, 2008
Earthtimes (press release) - May 13, 2008
SAN DIEGO , May 12 - - Neurocrine Biosciences , Inc . ( Nasdaq : NBIX ) announced today that Neurocrine Biosciences will present at the Citi Investment Research Global Health Care Conference ...
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
Date: Mon, 12 May 2008 19:15:34 GMT
Tags:
Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference
PR Newswire (press release) - May 12, 2008
PR Newswire (press release) - May 12, 2008
SAN DIEGO , May 12 / PRNewswire - FirstCall / - - Neurocrine Biosciences , Inc . NASDAQ : NBIX announced today that Neurocrine Biosciences will present at the Citi Investment Research Global ...
The Growth Stocks You Should Be Buying (at Motley Fool)
Date: Mon, 7 Jul 2008 20:51:51 Etc/GMT
Tags:
Vanda's Drug Draws a Yawn (at Motley Fool)
Date: Fri, 27 Jun 2008 19:08:22 Etc/GMT
Tags:
Neurocrine Pipeline Trickles (Zacks.com)
Date: Wed, 18 Jun 2008 12:44:04 Etc/GMT
Tags:
We have removed all U.S. indiplon revenues from our model, and continue to believe the drugs path to market is going to be extremely difficult.
Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis (PR Newswire)
Date: Tue, 17 Jun 2008 12:00:00 Etc/GMT
Tags:
Neurocrine Biosciences, Inc. announced today that the elagolix 0603 Phase IIb trial has completed the 6-month treatment phase. The last subject completed her Week 24 study visit in early June.
NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Other Events (EDGAR Online)
Date: Wed, 28 May 2008 21:13:27 Etc/GMT
Tags: